• Nenhum resultado encontrado

[PDF] Top 20 Use of ipscs for the treatment of neurodegenerative diseases

Has 10000 "Use of ipscs for the treatment of neurodegenerative diseases" found on our website. Below are the top 20 most common "Use of ipscs for the treatment of neurodegenerative diseases".

Use of ipscs for the treatment of neurodegenerative diseases

Use of ipscs for the treatment of neurodegenerative diseases

... None of the pharmacological treatments available nowadays for AD has the capacity to slow or completely cease the deterioration and loss of neurons, which causes the ... See full document

66

Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases

Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases

... used the combination of polymers to obtain the desired release profile, it is extremely important the knowledge of its characteristics and influence in the formulation, in order ... See full document

13

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

... contrast, treatment of 6-OHDA-intoxicated mice with catalase-transfected macrophages resulted in the decreased levels of CD11b and 65% less activated microglia cells compared with ... See full document

16

A review of intravenous immunoglobulins use on treatment and management of infectious diseases: the road so far

A review of intravenous immunoglobulins use on treatment and management of infectious diseases: the road so far

... to the antigenicity of the IgG itself, large molecular weight IgG aggregates, the presence of an antibody to a circulating microbial antigens or self-antigens, complement activation or ... See full document

25

Bisphosphonates in the treatment of metabolic bone diseases

Bisphosphonates in the treatment of metabolic bone diseases

... effects of alendronate and other bisphosphonates may last for long periods after discontinuation of ...discontinuation of the drug during which patients would still be protected from increased ... See full document

7

Discovery of target directed drugs for neurodegenerative diseases based on benzopyrone scaffold

Discovery of target directed drugs for neurodegenerative diseases based on benzopyrone scaffold

... instance, the use of herbal medicines containing khellin ...268 The extract of Ammi visnaga, from which khellin was isolated, has a cardioprotective effect, due to its vasorelaxant ... See full document

307

Use of decompressive craniectomy in the treatment of hemispheric infarction

Use of decompressive craniectomy in the treatment of hemispheric infarction

... 50% of the vascular territory of the middle cerebral artery, or the ante- rior and middle cerebral arteries territories simultaneously, asso- ciated with early brain swelling signs, ... See full document

5

Probiotics and the treatment of peri-implant diseases: a systematic review

Probiotics and the treatment of peri-implant diseases: a systematic review

... result of to the variety of measurement methodologies, there is a need for additional studies that use a similar and equal methodology, which would make the comparison of results ... See full document

58

Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal

Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal

... sales of medicines, which depend on the willingness or possibility of patients to fill their ...discussion of the correlation between prescrip- tions and sales, a proper interpretation ... See full document

11

Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.

Development of the CHARIOT Research Register for the Prevention of Alzheimer's Dementia and Other Late Onset Neurodegenerative Diseases.

... in the general ...45% of studies recruiting less than their target and 54% of trials requiring an extension to fulfil recruitment obligations ...on the active engagement of clinicians ... See full document

14

Polyphenols and Neurodegenerative Diseases

Polyphenols and Neurodegenerative Diseases

... to the cascade of events culminating in the progressive neuronal damage observed in many neurodegenerative disorders , most notably AD and PD, 225-226 and also with neuronal injury associated ... See full document

46

The use of stem cells for the treatment of autoimmune diseases

The use of stem cells for the treatment of autoimmune diseases

... model of the protocol for obtaining autologous hematopoietic stem cells from peripheral blood for transplantation showing the different stages of transplantation, re-establishment of ... See full document

19

Coenzyme Q(10) and its effects in the treatment of neurodegenerative diseases

Coenzyme Q(10) and its effects in the treatment of neurodegenerative diseases

... whether the treatment with CoQ 10 could beneit patients with PD, Shults et ...administration of CoQ 10 might be beneicial in a laboratory model of ...and the irst to be impaired in PD. ... See full document

12

Quality of Life in Patients with Neurodegenerative Diseases

Quality of Life in Patients with Neurodegenerative Diseases

... impairment of these areas affects negatively the activities of daily living (ADL) in patients with Parkinson's disease, not only the basic physical activities, with instrumental activities ... See full document

7

Use of a Smartphone for Self-Management of Pulmonary Diseases

Use of a Smartphone for Self-Management of Pulmonary Diseases

... non-pharmacological treatment, pulmonary rehabilitation is an effective therapeutic pro- gram that provides benefits over and above those that can be achieved with medications alone ...towards the reduction ... See full document

82

Classical and recent advances in the treatment of inflammatory bowel diseases

Classical and recent advances in the treatment of inflammatory bowel diseases

... for treatment of perianal fistulizing CD had 30% fistula remission after 10 weeks of therapy compared with 0 and ...12.5% of fistula remission achieved with metronidazole or placebo, ... See full document

12

Use of vasopressin in the treatment of refractory septic shock

Use of vasopressin in the treatment of refractory septic shock

... for the treatment of septic shock in cases that are refractory to norepinephrine, as defined by the attending ...physician. The patients were identified through a computerized ... See full document

6

PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review

PCSK9 Inhibitors in the Treatment of Cardiovascular Diseases: A Narrative Review

... trial, the authors randomized 18924 patients, who were more than 40 years of age, had a recent ACS within 1 to 12 months prior to randomization and who had an LDL-c level more than 70 mg/dl, or non-HDL-c ... See full document

37

Use of Hepar sulphur for treatment of alveolitis

Use of Hepar sulphur for treatment of alveolitis

... assess the effectiveness of homeopathic treatment. All the participants received Hepar sulphur 30cH for 10 days and were assessed 1,2, 3, 5, 7 and 10 ...all the participants (98%) pain ... See full document

6

Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases

Strategies for the inhibition of gingipains for the potential treatment of periodontitis and associated systemic diseases

... fruit of the domesticated legume, Canavalia gladiate (commonly referred to as sword bean), is used in Chinese and Japanese herbal medicine for treating pus ...discharge. The fruit contains ... See full document

12

Show all 10000 documents...